These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34870154)

  • 1. Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients.
    Vitiello A; Ferrara F
    Curr Res Pharmacol Drug Discov; 2021; 2():100056. PubMed ID: 34870154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy.
    Vitiello A; Pelliccia C; Ferrara F
    SN Compr Clin Med; 2020; 2(10):1709-1712. PubMed ID: 32875276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
    Ferrara F; Granata G; Pelliccia C; La Porta R; Vitiello A
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1615-1618. PubMed ID: 32594204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
    George PM; Wells AU; Jenkins RG
    Lancet Respir Med; 2020 Aug; 8(8):807-815. PubMed ID: 32422178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary fibrosis in patients with COVID-19: A review].
    Chuchalin AG
    Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human-Based Advanced
    Kiener M; Roldan N; Machahua C; Sengupta A; Geiser T; Guenat OT; Funke-Chambour M; Hobi N; Kruithof-de Julio M
    Front Med (Lausanne); 2021; 8():644678. PubMed ID: 34026781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.
    Bazdyrev E; Panova M; Brachs M; Smolyarchuk E; Tsygankova D; Gofman L; Abdyusheva Y; Novikov F
    J Transl Med; 2022 Nov; 20(1):506. PubMed ID: 36329513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
    Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Richeldi L; Corsico AG
    Cells; 2021 May; 10(5):. PubMed ID: 34068958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
    Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
    bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary fibrotic-like changes on follow-up chest CT exam in patients recovering from COVID-19 pneumonia.
    Vural A; Kahraman AN
    Tuberk Toraks; 2021 Dec; 69(4):492-498. PubMed ID: 34957743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia.
    Bazdyrev E; Panova M; Zherebtsova V; Burdenkova A; Grishagin I; Novikov F; Nebolsin V
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic.
    Ambardar SR; Hightower SL; Huprikar NA; Chung KK; Singhal A; Collen JF
    J Clin Med; 2021 Jun; 10(11):. PubMed ID: 34205928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.
    Edler C; Schröder AS; Aepfelbacher M; Fitzek A; Heinemann A; Heinrich F; Klein A; Langenwalder F; Lütgehetmann M; Meißner K; Püschel K; Schädler J; Steurer S; Mushumba H; Sperhake JP
    Int J Legal Med; 2020 Jul; 134(4):1275-1284. PubMed ID: 32500199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
    Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung transplantation for pulmonary fibrosis secondary to severe COVID-19.
    Bharat A; Querrey M; Markov NS; Kim S; Kurihara C; Garza-Castillon R; Manerikar A; Shilatifard A; Tomic R; Politanska Y; Abdala-Valencia H; Yeldandi AV; Lomasney JW; Misharin AV; Budinger GRS
    medRxiv; 2020 Oct; ():. PubMed ID: 33140069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief review of the mRNA vaccines COVID-19.
    Vitiello A; Ferrara F
    Inflammopharmacology; 2021 Jun; 29(3):645-649. PubMed ID: 33932192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Review.
    Chen X; Zhang G; Hao SY; Bai L; Lu JJ
    Chin Med Sci J; 2020 Sep; 35(3):254-261. PubMed ID: 32972503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.